|
|
Volumn 19, Issue 2, 2013, Pages 131-133
|
|
Apoptosis therapy: Driving cancers down the road to ruin
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABT 199;
ANTINEOPLASTIC AGENT;
BH3 PROTEIN;
DEATH RECEPTOR;
NAVITOCLAX;
PROTEIN BAK;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN BCL XL;
RITUXIMAB;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CANCER THERAPY;
CHRONIC LYMPHATIC LEUKEMIA;
CYTOSOL;
HEMATOLOGIC MALIGNANCY;
HUMAN;
MEMBRANE PERMEABILITY;
MITOCHONDRIAL MEMBRANE;
MOLECULARLY TARGETED THERAPY;
PRIORITY JOURNAL;
THROMBOCYTE;
TUMOR GROWTH;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BICYCLO COMPOUNDS, HETEROCYCLIC;
BLOOD PLATELETS;
FEMALE;
HEMATOLOGIC NEOPLASMS;
HUMANS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
SULFONAMIDES;
|
|
EID: 84873535801
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3076 Document Type: Article |
|
Times cited : (40)
|
|
References (10)
|
